Found 92 matching trials
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding
PHASE3This trial is conducted globally. The purpose of the trial is to evaluate t...
Location
Novo Nordisk Clinical Trial Call Center
Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers
PHASE1This trial is conducted in Europe. The aim of this trial is to investigate ...
Location
Novo Nordisk Investigational Site
Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
N/AThis NON INTERVENTIONAL OBSERVATIONAL STUDY is conducted in Europe. The pri...
Location
Novo Nordisk Investigational Site
Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion
N/AThis study aims to compare the incidence of thromboembolic complications am...
Location
UF Health Jacksonville (Shands Hospital)
Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B
N/ASevere haemophilia A and B (SHA, SHB) are X - linked inherited bleeding dis...
Location
Royal Free Hospital
Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Study at the University Hospital of Bern
N/AThis non-interventional study will compare the clinical outcomes in women w...
Location
Novo Nordisk Investigational Site
Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B
N/AThis study is conducted in Europe and Asia. The aim of this observational s...
Location
Multiple Locations
A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150
PHASE2Haemophilia is a disorder, usually genetic, affecting mostly male individua...
Location
Multiple Locations
Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
EARLY_PHASE1This trial will enroll patients with severe hemophilia A. Experiments will ...
Location
Tulane University Lakeside Hospital and Clinics
Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor
PHASE3Human coagulation factor VII is a vitamin K-dependent serine endogenous pro...
Location
The Second Affiliated Hospital of Chongqing Medical University